The Us2.ai algorithm is a groundbreaking AI decision support tool that redefines the way echocardiograms are interpreted. This algorithm facilitates the detection of a wide array of heart-related conditions, from heart failure to pulmonary hypertension, in line with international guidelines. Developed with full automation in mind, Us2.ai’s technology minimizes manual interventions and makes echocardiogram analysis accessible, consistent, and inexpensive. With FDA clearance and international acceptance, Us2.ai is paving the way for a new standard in cardiac care.
Focused on cardiac care, specifically in the detection of multiple heart-related conditions like heart failure and pulmonary hypertension.
Ideal for healthcare providers looking to improve patient outcomes through advanced, consistent, and scalable echocardiogram analysis.
Founded as the first spinout from an 11-country cardiovascular research platform, Us2.ai aims to democratize echocardiograms, the most widely used tool for detecting heart risks. With a global reach that extends from tech-advanced regions to resource-constrained communities, the company has rapidly gained recognition, including a $15 million Series A funding round led by notable investors. Its mission aligns with the urgent need to address cardiovascular disease, the leading global cause of death.
by RemedyLogic
RemedyLogic provides AI-powered spine MRI interpretation tools designed to strea
by VUNO Inc.
VUNO Med®-DeepBrain® is a highly accurate, fast atrophy and WMH measurement AI
by Qure.AI
qXR is an AI-based solution for comprehensive chest X-Ray reporting. It provides
Let’s collaborate to harness the transformative power of these advanced technologies, propelling your medical practice to unprecedented levels of diagnostic accuracy, efficiency, and patient care.
Redeem your demo!